The Latest Breaking News from Obesity

After a long, stressful day at work, or when pressed for time, the temptation to have a quick, satisfying snack – like crisps or a chocolate bar – can be strong. Research shows that these ultra-processed, high-calorie foods play a significant role in the development of obesity, but the lasting…

The ultramarathon runner is set to run a 3,000km mountainous trail which spans the length of New Zealand

Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease.

Dog that are constantly hungry may share the same gene as humans who are more likely to be obese

Pippa flops by the Aga oven chewing on a stick. At just 12 weeks old, this labrador retriever puppy looks cute but clueless. But when she hears the word “biscuit”, her entire demeanour changes. Ears pricked, she’s immediately at her owner’s feet, gazing adoringly, sitting, even woofing on command.

Non-communicable diseases such as diabetes, hypertension and cardiovascular conditions account for over 70% of global deaths annually.

Stigma, lack of treatment and disproportionate rise of the disease in women draws comparisons with HIV epidemic

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance

Many people who have struggled with their weight have been told to “eat less and move more.” Others have spent years juggling trendy diets, from keto to fasting, with minimal results. Despite their best efforts, what they often hear from physicians, friends, family and even strangers, is that they lack…

More than half of adults will also be overweight or have obesity in the same timeframe, researchers say

Wegovy, Zepbound, Saxenda, and other GLP-1 or GIP medications are needlessly out of reach for many Americans.